Furthermore, the ONCOS-207, ONCOS-209, ONCOS-207 + ONCOS-209, ONCOS-210, and ONCOS-212 groups significantly increased the percentage of PD-L2 + A2058 tumor cells (Figure S4B). This evidence concerns the gene PDCD1LG2 and neoplasm.